West Pharmaceutical Servs (WST) closed at $412.55 on November 10, 2026, down 0.1% from the previous close, on volume of 394,882 shares (30-day average 653,796).
Data as of November 10, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 2, 2026 | Double Diagonal | 18-Dec-26240 P : 330 C|17-Dec-27360 P : 490 C | 960 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
West to Participate in Upcoming Investor Conference
PRNewswire (Wed, 4-Nov 6:00 AM ET)
West Pharmaceutical (WST) lifts 2026 guidance as HVP Components reach 53% of quarterly sales
Market Chameleon (Thu, 29-Oct 4:39 AM ET)
West Reports Third-Quarter 2026 Results
PRNewswire (Thu, 29-Oct 6:01 AM ET)
West Declares Quarterly Dividend
PRNewswire (Mon, 19-Oct 6:04 PM ET)
West to Host Third-Quarter 2026 Conference Call
PRNewswire (Thu, 8-Oct 6:02 AM ET)
West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
PRNewswire (Mon, 5-Oct 6:00 AM ET)
West to Participate in Upcoming Investor Conferences
PRNewswire (Wed, 26-Aug 4:00 PM ET)
West Pharmaceutical Services Raises Full-Year Guidance as High-Value Products Drive 21% Sales Growth
Market Chameleon (Thu, 23-Apr 7:45 AM ET)
West Pharmaceutical Lifts 2025 Outlook on Double-Digit HVP Component Growth and Strong Cash Flow
Market Chameleon (Thu, 23-Oct 4:26 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of November 10, 2026, WST stock price declined to $412.55 with 394,882 million shares trading.
WST has a beta of 0.59, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.05 to the broad based SPY ETF.
WST has a market cap of $28.74 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $874 million in Revenue and $2.66 earnings per share. This beat revenue expectation by $48 million and exceeded earnings estimates by $.47.
In the last 3 years, WST traded as high as $438.27 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, IVV, VUG.
WST has outperformed the market in the last year with a price return of +52.5% while the SPY ETF gained +12.9%. WST has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +16.5% and +4.5%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
WST support price is $405.35 and resistance is $420.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.
